Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Arlington, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Eloxx Pharmaceuticals, Inc. has filed 1,350 SEC EDGAR filings since 27 Mar 1997

SEC filing history

Showing 676-700 of 917 matching filings.

Per page
25
Current page
28
424B5 File 333-170140

424B5

Filing date
07 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

FORM 8-K

Filing date
04 Jan 2013
Reporting date
04 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

CURRENT REPORT

Filing date
10 Dec 2012
Reporting date
10 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 Nov 2012
Reporting date
26 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

FORM 8-K

Filing date
26 Nov 2012
Reporting date
26 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 Nov 2012
Reporting date
21 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 001-31326

25-NSE filing

Filing date
23 Nov 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

FORM 8-K

Filing date
21 Nov 2012
Reporting date
21 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K

Filing date
19 Nov 2012
Reporting date
16 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Nov 2012
Reporting date
16 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Nov 2012
Reporting date
16 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Nov 2012
Reporting date
16 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Nov 2012
Reporting date
16 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Nov 2012
Reporting date
16 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Nov 2012
Reporting date
16 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Nov 2012
Reporting date
16 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Nov 2012
Reporting date
16 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Nov 2012
Reporting date
16 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Nov 2012
Reporting date
16 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Nov 2012
Reporting date
16 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Nov 2012
Reporting date
16 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

FORM 8-K

Filing date
15 Nov 2012
Reporting date
15 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

FORM 8-K

Filing date
07 Nov 2012
Reporting date
07 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-31326

FORM 10-K/A

Filing date
26 Oct 2012
Reporting date
30 Jun 2012
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .